Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare


TAIPEI, Taiwan, Feb. 11, 2019 /PRNewswire/ -- An exclusive license agreement for the commercialisation of Foresee Pharmaceutical's (6576.TWO) novel FP-001 program ... Lees verder

Bron: ANP Pers support
Geplaatst: 11 feb 2019 - 11:36